Lopez Carlos Luis has filed 3 insider transactions across 1 company since February 2025.
Most recent transaction: a grant/award of 41420 shares of Niagen Bioscience, Inc. ($NAGE) on February 19, 2026.
Activity breakdown: 1 open-market purchase and 0 sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 19, 2026 | Niagen Bioscience, Inc. | $NAGE | Lopez Carlos Luis | SVP, General Counsel | A | Employee Stock Options (right to buy) | 41420 | $0.00 | 41,420.0000 | 86,619,000 | 9999.99% | 0.05% |
| March 7, 2025 | Niagen Bioscience, Inc. | $NAGE | Lopez Carlos Luis | SVP, General Counsel | P | Common Stock | 273 | $7.86 | 2,251.0000 | 78,125,000 | 13.80% | 0.00% |
| Feb. 12, 2025 | Niagen Bioscience, Inc. | $NAGE | Lopez Carlos Luis | SVP, General Counsel | A | Employee Stock Options (right to buy) | 19691 | $0.00 | 19,691.0000 | 78,125,000 | 9999.99% | 0.03% |